Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah ... [et al.]

Adjuvant trastuzumab has been used in human epidermal growth factor-2 (HER2) breast cancer to improve survival but with concern of cardiotoxicity. Our study is the first to review efficacy and toxicity of adjuvant trastuzumab in Malaysia. Methods: This is a retrospective cohort study on HER2 non met...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Hasbullah, Harissa H (Auteur), Bustamam, Anita (Auteur), Tho, Lye Munn (Auteur), Phua, Vincent (Auteur)
Formaat: Boek
Gepubliceerd in: Universiti Teknologi MARA Cawangan Selangor, 2018-06.
Onderwerpen:
Online toegang:Link Metadata
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items